Healthcare [ 12/13 ] | Biotechnology [ 116/164 ]
NASDAQ | Common Stock
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States.
It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies.
In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies.
Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes.
The company was founded in 1996 and is based in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 6, 24 | 0.98 Decreased by -38.75% | 0.98 |
| Mar 5, 24 | 1.15 Decreased by -26.28% | 1.01 Increased by +13.86% |
| Nov 8, 23 | 0.79 Increased by +9.72% | 0.76 Increased by +3.95% |
| Aug 8, 23 | 0.84 Increased by +6.33% | 0.81 Increased by +3.70% |
| May 9, 23 | 1.60 Increased by +166.67% | 1.27 Increased by +25.98% |
| Feb 15, 23 | 1.56 Increased by +95.00% | 1.47 Increased by +6.12% |
| Nov 8, 22 | 0.72 Increased by +323.53% | 0.72 |
| Aug 4, 22 | 0.79 Decreased by -26.85% | 0.78 Increased by +1.28% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 24 | 567.98 M Decreased by -16.96% | 4.78 M Decreased by -98.60% | Increased by +0.84% Decreased by -98.31% |
| Dec 31, 23 | 596.00 M Increased by +5.35% | 494.34 M Increased by +181.02% | Increased by +82.94% Increased by +176.90% |
| Sep 30, 23 | 536.31 M Decreased by -6.48% | 72.11 M Decreased by -66.89% | Increased by +13.45% Decreased by -64.60% |
| Jun 30, 23 | 538.20 M Increased by +0.42% | 227.63 M Decreased by -25.25% | Increased by +42.29% Decreased by -25.56% |
| Mar 31, 23 | 683.97 M Increased by +21.69% | 340.75 M Increased by +954.58% | Increased by +49.82% Increased by +802.25% |
| Dec 31, 22 | 565.75 M Decreased by -1.73% | -610.17 M Decreased by -7.82 K% | Decreased by -107.85% Decreased by -7.96 K% |
| Sep 30, 22 | 573.46 M Decreased by -2.10% | 217.83 M Increased by +113.71% | Increased by +37.99% Increased by +118.30% |
| Jun 30, 22 | 535.96 M Decreased by -3.43% | 304.50 M Decreased by -30.92% | Increased by +56.82% Decreased by -28.47% |